Clinical trial
A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of…
NCT00462670 · Otsuka Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00462670 |
|---|---|
| Title | A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure) |
| Official title | A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure) |
| Lead sponsor | Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Edema, Cardiac |
| Intervention type | Drug |
| Interventions | OPC-41061(Tolvaptan) |
| Enrollment | 110 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Apr 19, 2007 |
| Last update posted | Feb 4, 2014 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: